Live Breaking News & Updates on As Azn Gb0009895292
Stay updated with breaking news from As azn gb0009895292. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AstraZeneca PLC on Wednesday said the European Commission approved its drug Ultomiris in the EU for adults with autoimmune disease neuromyelitis optica spectrum disorder, known as NMOSD.
-Britain s medicines regulator has approved AstraZeneca s antibody-based COVID-19 treatment for adults with poor immune response, marking a major step in the fight against the pandemic as infections. | March 17, 2022 ....
The Omicron coronavirus variant, reported in more than 60 countries, poses a very high global risk, with some evidence that it evades vaccine protection but clinical data on its severity is limited,. | December 14, 2021 ....